Core Viewpoint - Abivax SA has published its financial communications calendar for 2025, outlining key dates for financial reporting and meetings [2][4]. Financial Reporting Schedule - The 2024 Annual Business and Financial Report will be released on March 24, 2025, after US market closes [3]. - The 2025 Q1 Financial Results are scheduled for June 2, 2025, after US market closes [3]. - The 2025 Half-Year Business and Financial Report will be available on August 11, 2025, after US market closes [4]. - The 2025 Q3 Financial Results will be published on December 15, 2025, after US market closes [4]. - The 2025 Annual General Meeting (AGM) will take place on June 6, 2025, in Paris, France [3]. Company Overview - Abivax is a clinical-stage biotechnology company focused on developing therapies for chronic inflammatory diseases [4]. - The company's lead drug candidate, obefazimod (ABX464), is currently in Phase 3 clinical trials for treating moderately to severely active ulcerative colitis [4].
Abivax Publishes 2025 Financial Calendar